AAAyfer Arduç Akçay

Ayfer Arduç Akçay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayfer Arduç Akçay has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hereditary Polyneuropathy Experience of a Tertiary Single‐Center in Türkiye: Beyond the Tip of the Iceberg

    by Şahin Avcı, Serpil Eraslan, Gulshan Yunisova, Merve Kaysin, Ayşe Nur Özdağ Acarlı, Ayfer Arduç Akçay, Hülya Kayserili, Z. Piraye Oflazer

    Hereditary polyneuropathies (HPPs), including Charcot–Marie–Tooth disease (CMT), represent a genetically and clinically heterogeneous group of disorders. Overlapping phenotypes, genetics, and clinical heterogeneity, and more complex phenotypes mimicking CMT can complicate the diagnosis. This study evaluated the effectiveness of an algorithm‐guided, broad genetic testing strategy in a tertiary neuromuscular center in Türkiye, where recessive disorders are relatively common. Sixty‐seven patients from 63 families referred for suspected HPP (2018–2025) were clinically stratified by phenotype and electrophysiology, and a diagnostic workflow integrating PMP22 MLPA with clinical or whole‐exome sequencing was applied. The overall molecular diagnostic yield was 73% (46/63). PMP22 ‐related neuropathies accounted for 43.5% of all diagnosed cases, with a group‐specific yield of 60%. Among the non‐ PMP22 CMT group, the predominant inheritance pattern was autosomal recessive (70%). Nine novel variants were identified. Two dual molecular diagnoses ( PMP22 / MCCC1 ; MPZ / CRYBB2 ) were established. Importantly, six patients initially labeled as “CMT‐like” harbored non‐CMT disorders, including CYP27A1 ‐, BTD ‐, HEXB ‐, ZFYVE26 ‐, C19ORF12 ‐, and COA7 ‐related diseases—several of which are treatable or actionable. In a population with high genetic heterogeneity and elevated consanguinity, reliance on narrow CMT‐focused panels risks misdiagnosis and may miss therapeutic opportunities. An algorithm‐driven approach integrating PMP22 CNV analysis with exome sequencing substantially improves diagnostic yield, reveals blended or digenic mechanisms, and helps distinguish non‐CMT phenocopies. These findings underscore the importance of comprehensive genomic testing and careful phenotype–genotype correlation in the evaluation of hereditary polyneuropathies.

  • Open Access

    Neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: an important yet overlooked diagnosis in pediatric ataxia

    by Ayfer Arduç Akçay, Banu Oflaz Sözmen, Mehmet Fatih Erbey, Serap Uysal, Rejin Kebudi

    Background. Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare, immune-mediated neurological disorder, often associated with neuroblastoma (NB) in children. This study aimed to describe the clinical features, diagnostic challenges, treatment, and outcomes of pediatric patients with NB-associated OMAS. Methods. We retrospectively reviewed medical records of seven children diagnosed with NB-associated OMAS between November 1, 2015 and January 31, 2025. Data on demographics, clinical presentation, tumor characteristics, treatment protocols, relapses, and outcomes were collected. The Mitchell-Pike OMS Rating Scale was used to assess severity. Results. The cohort included four girls and three boys, aged 18–36 months (median 31). All had a history of infection and/or vaccination preceding symptom onset. Ataxia was the most common initial symptom (6/7, 85.7%), followed by behavioral disturbances and sleep disorders (5/7, 71.4% each). At presentation, opsoclonus was present in two patients, which was initially misdiagnosed as nystagmus. All but one patient had opsoclonus during the disease course. Neuroblastomas were located in abdominal (n=4), thoracic (n=1), and sacral (n=2) regions; all tumors measured


  • Sociodemographic Profiles and Age-Related Differences in Comorbidities, Sleep, and Quality of Life of Turkish Children with Rett Syndrome and their Families

    by Ayfer Arduç Akçay, Gaye Türkmen Noyan, İlAy Çalışkan, Belgin Konakçı, Sidar Copur, Tuba Mutluer

    This study aimed to examine sociodemographic characteristics, comorbid medical conditions, sleep problems, and their impact on quality of life (QoL) in Turkish children with Rett Syndrome (RTT) and their caregivers. A secondary aim was to explore how these features vary by age group: early (0–5), middle (6–11), and late childhood (12–18 years). In this cross-sectional study, 74 children with RTT and their caregivers completed standardized online questionnaires. QoL and sleep were assessed using the PedsQL and Children's Sleep Habits Questionnaire. Participants were grouped by age to examine developmental differences. Only 37.8% of the children had developed speech, and most later lost this ability. Independent walking was reported in 43.2%. Epilepsy (71.6%) and gastrointestinal symptoms (56.8%) were common. Parasomnia symptoms significantly more common in the 0 to 5 age group (p = 0.039). Emotional functioning was lower in younger children (p = 0.022). Poor sleep quality was associated with worse family relations (p = 0.032). Younger children with RTT experience more emotional and sleep problems. Sleep quality is closely tied to family well-being, suggesting that interventions should address sleep in both children and caregivers.

  • Open Access

    A rare presentation of pediatric MOG-antibody-associated neuroretinitis: a case report

    by Ayfer Arduç-Akçay, Yusuf Hüseyin Berrak, Ayşe Yıldız-Taş

    Neuroretinitis (NR) is an uncommon inflammatory optic neuropathy characterized by optic disc edema and macular exudates. Although NR may arise from infecti

  • Congenital Myasthenic Syndrome: Long‐Term Outcomes up to 60 Years, Molecular Characterization, and Eight Novel Variants

    by Ayfer Arduç Akçay, Gulshan Yunisova, Şahin Avcı, Ayşe Nur Özdağ Acarlı, Hülya Kayserili, Piraye Oflazer

    Congenital myasthenic syndrome (CMS) refers to a rare heterogeneous group of hereditary disorders characterized by fatigue and muscle weakness due to impairment in neuromuscular transmission. A total of 40 genes have been identified in the pathogenesis of CMSs. The study assessed 22 patients (14 females and 8 males) with CMS of childhood onset with their phenotypes and genotypes. Genetic analysis revealed variations in the following eight genes: CHRNE , DOK7 , GFPT1 , COLQ , SLC25A1 , CHAT , MUSK , and MYO9A. Eight novel variations were detected involving SLC25A1 , MUSK , DOK7 , GFPT1 , and CHRNE . The median age was 14 years (range: 0.5–67 years). The median age of onset of symptoms was 8 months (range: 0–16 years). The longest time after the onset of symptoms was 62 years. The most common initial symptoms were weakness of extremities ( n = 9) and ptosis ( n = 8). Respiratory symptoms were present in 11 patients (50%), which showed progression, multiphasic disease course, and amelioration in 45.4%, 18.1%, and 36.3% of patients, respectively. Motor symptoms showed a progressive worsening in 68.1%, stationary course in 13.6%, multiphasic disease course in 13.6%, and amelioration in 4.5% of patients. Thanks to next‐generation sequencing, diagnoses of CMS have been increasing over the recent years; so has the number of novel variants.


  • Occipital emissary vein existence and its impact on the diagnosis of idiopathic intracranial hypertension in pediatric patients

    by Evrim Özmen, Ayfer Arduç Akçay, Yunus Emre Şentürk, Ahmet Peker, Yusuf Öner

    Purpose This study aimed to investigate the efficacy of occipital emissary vein (OEV) detection in the diagnosis of idiopathic intracranial hypertension (IHH) in the pediatric age group, and to compare the prevalence and luminal diameter of OEV in patients with IHH and in healthy control subjects. Methods Conventional magnetic resonance imaging findings were assessed in the patients with IHH and in healthy control subjects who were under the age of 18, by two observers. The presence and luminal dimension of OEV and transverse sinus stenosis were also evaluated and compared between these two groups with magnetic resonance venography techniques. Results The rate of OEV existence was 7 times higher in the IIH group compared to the control group based on the second observer outcome (p = 0.010, OR = 7.0), with a very good interobserver agreement (Ƙ = 0.85). The dimension of OEV ranged between 0.6 and 2.5 mm. There was no correlation found between the opening pressure and the dimension of OEV (p = 0.834). Conclusion In conclusion, OEV existence could be an additional radiological finding for diagnosing IHH among pediatric patients, alongside other conventional findings.